Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, March 08, 2023
Lonza announced an enhancement to its powder characterization capabilities at its Small Molecules site in Tampa, Florida (US).
read more
Calyx, an eClinical and Regulatory solutions and services provider announced the availability of Calyx Supply Simulation, a clinical trial supply forecasting service available through Calyx's in-house expert statistical design and trial supplies ...
read more
Catalent announced the appointment of Sridhar Krishnan, to the newly created position of Vice President, The Catalent Way.
read more
Indivior has acquired Opiant Pharmaceuticals. The transaction strengthens Indivior's addiction treatment and science portfolio by adding Opiant's late-stage assets, notably OPNT003, an investigational opioid overdose treatment designed to offer an ...
read more
Wednesday, March 01, 2023
ArisGlobal, a leading provider of life sciences software designed to automate core drug development functions with its end-to-end technology platform LifeSphere® announced the acquisition of Amplexor Life Sciences (LS), a global provider of ...
read more
Tuesday, February 28, 2023
Syneos Health® a fully integrated biopharmaceutical solutions organization, announced the launch of a Decentralized Clinical Trial (DCT) Site Network to drive appropriate DCT adoption and enable high quality delivery of DCTs and digital health ...
read more
Tuesday, February 28, 2023
ValGenesis, Inc. and Rephine have partnered to offer compliance solutions to global pharmaceutical companies seeking to improve quality assurance (QA) throughout their supply chains.
read more
Tuesday, February 28, 2023
Clinical ink, a global life science technology company, announced a strategic alliance with The Boston Clinical Research Institute (BCRI), an Academic Research Organization (ARO) based in Boston, Massachusetts.
read more
Tuesday, February 28, 2023
Simris Alg AB (publ), a European biologics company that focuses on extracting high-value biological active compounds from microalgae and cyanobacteria, has announced a framework collaboration agreement with Lonza Ltd.
read more
Tuesday, February 28, 2023
Absci Corporation, a generative AI drug creation company, announced its expansion into the European pharmaceutical market with the opening of its Innovation Center, located in Zug, Switzerland.
read more
Thursday, February 23, 2023
AllCells®, a Discovery Life Sciences™ company announced the expansion of its apheresis network with the addition of two new centers in Houston, Texas, and Huntsville, Alabama. These new centers complement AllCells' existing presence in two major U.S....
read more
Wednesday, February 22, 2023
The development of a new enzyme for double strand oligonucleotide formation with high productivity has been announced by Ajinomoto Bio-Pharma Services, a leading provider of biopharmaceutical contract development and manufacturing services.
read more
Friday, February 17, 2023
Charles River Laboratories International and Purespring Therapeutics, a gene therapy company dedicated to transforming the treatment of kidney diseases, have announced a plasmid DNA contract development and manufacturing organization (CDMO) ...
read more
Friday, February 17, 2023
Charles River Laboratories International, Inc. announced a multi-program agreement with Pioneering Medicines, a strategic initiative of Flagship Pioneering, that gives Pioneering Medicines access to Logica™.
read more
Friday, February 17, 2023
Lonza has completed its planned expansion of the bioconjugation facility in Visp (CH). The expansion includes two new manufacturing suites and supporting infrastructure to accommodate a wider range of customers, including companies entering clinical ...
read more